Sartorius Stedim Biotech Stock Analysis

Sartorius Pink Sheet Analysis Notes

About 74.0% of the company outstanding shares are owned by corporate insiders. The company recorded earning per share (EPS) of 7.94. Sartorius Stedim Biotech last dividend was issued on the 31st of March 2022. The entity had 6:1 split on the 6th of May 2016. Sartorius Stedim Biotech S.A. produces and sells instruments and consumables for the biopharmaceutical industry worldwide. Sartorius Stedim Biotech S.A. is a subsidiary of Sartorius AG. Sartorius Stedim operates under Medical Instruments Supplies classification in the United States and is traded on OTC Exchange. It employs 10409 people.The quote for Sartorius Stedim Biotech is published daily by the National Quotation Bureau and the company does not need to meet minimum requirements or file with the SEC. To find out more about Sartorius Stedim Biotech contact Joachim Kreuzburg at 33 4 42 84 56 00 or learn more at https://www.sartorius.com.

Sartorius Stedim Biotech Investment Alerts

Sartorius Market Capitalization

The company currently falls under 'Large-Cap' category with a current market capitalization of 34.9 B. Market capitalization usually refers to the total value of a company's stock within the entire market. To calculate Sartorius Stedim's market, we take the total number of its shares issued and multiply it by Sartorius Stedim's current market price. To manage market risk and economic uncertainty, many investors today build portfolios that are diversified across equities with different market capitalizations. However, as a general rule, conservative investors tend to hold large-cap stocks, and those looking for more risk prefer small-cap and mid-cap equities.

Sartorius Profitablity

The company has Profit Margin (PM) of 0.2 %, which maeans that even a very small decline in it revenue will erase profits resulting in a net loss. This is way below average. Similarly, it shows Operating Margin (OM) of 0.3 %, which suggests for every 100 dollars of sales, it generated a net operating income of $0.3.

Technical Drivers

As of the 24th of July, Sartorius Stedim has the Variance of 6.48, coefficient of variation of (4,315), and Risk Adjusted Performance of (0.01). In relation to fundamental indicators, the technical analysis model makes it possible for you to check existing technical drivers of Sartorius Stedim Biotech, as well as the relationship between them. Please validate Sartorius Stedim Biotech standard deviation, as well as the relationship between the maximum drawdown and kurtosis to decide if Sartorius Stedim is priced more or less accurately, providing market reflects its prevalent price of 205.0 per share. Given that Sartorius Stedim Biotech has information ratio of (0.11), we advise you to double-check Sartorius Stedim Biotech's current market performance to make sure the company can sustain itself at a future point.

Sartorius Stedim Biotech Price Movement Analysis

Sartorius Stedim Predictive Daily Indicators

Sartorius Stedim Forecast Models

Sartorius Stedim's time-series forecasting models are one of many Sartorius Stedim's pink sheet analysis techniques aimed at predicting future share value based on previously observed values. Time-series forecasting models ae widely used for non-stationary data. Non-stationary data are called the data whose statistical properties e.g. the mean and standard deviation are not constant over time but instead, these metrics vary over time. These non-stationary Sartorius Stedim's historical data is usually called time-series. Some empirical experimentation suggests that the statistical forecasting models outperform the models based exclusively on fundamental analysis to predict the direction of the market movement and maximize returns from investment trading.

Pink Sheet analysis is the technique used by a trader or investor to examine and evaluate how Sartorius Stedim prices is reacting to, or reflecting on a current market direction and economic conditions. It can be used to make informed decisions about market timing, and when buying or selling Sartorius shares will generate the highest return on investment. We also built our pink sheet analysis module to help investors to gain an insight into the world economy as a whole, the stock market, thematic ideas. a specific sector, or an individual Pink Sheet such as Sartorius Stedim. By using and applying Sartorius Pink Sheet analysis, traders can create a robust methodology for identifying Sartorius entry and exit points for their positions.

When running Sartorius Stedim's price analysis, check to measure Sartorius Stedim's market volatility, profitability, liquidity, solvency, efficiency, growth potential, financial leverage, and other vital indicators. We have many different tools that can be utilized to determine how healthy Sartorius Stedim is operating at the current time. Most of Sartorius Stedim's value examination focuses on studying past and present price action to predict the probability of Sartorius Stedim's future price movements. You can analyze the entity against its peers and the financial market as a whole to determine factors that move Sartorius Stedim's price. Additionally, you may evaluate how the addition of Sartorius Stedim to your portfolios can decrease your overall portfolio volatility.